Cross Country Healthcare INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cross Country Healthcare, Inc. has filed a definitive proxy statement with the SEC under Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
Cross Country Healthcare reports $1.3 billion revenue in 2024, maintains strong balance sheet, and anticipates Q4 2025 merger close with Aya Healthcare amidst industry challenges.
NASDAQ
Cross Country Healthcare's merger with Aya Healthcare is now expected to close in the second half of 2025 due to a second request for information from the FTC.
NASDAQ
Cross Country Healthcare is set to be acquired by Aya Healthcare in a deal valued at $615 million, offering stockholders $18.61 per share in cash.
NASDAQ
Cross Country Healthcare has agreed to be acquired by Aya Healthcare, marking a significant milestone in its 40-year history.
NASDAQ
Aya Healthcare will acquire Cross Country Healthcare for $18.61 per share in cash, valuing the transaction at approximately $615 million.
NASDAQ
Cross Country Healthcare has entered into an agreement to be acquired by Aya Healthcare, with the transaction expected to close in the first half of 2025.
NASDAQ
Cross Country Healthcare has announced an agreement to be acquired by Aya Healthcare, with the transaction expected to close in the first half of 2025.
NASDAQ
Cross Country Healthcare has announced it will be acquired by Aya Healthcare, with the transaction expected to close in the first half of 2025.
NASDAQ
Cross Country Healthcare has announced it will be acquired by Aya Healthcare, with the transaction expected to close in the first half of 2025.
NASDAQ
Cross Country Healthcare has agreed to be acquired by Aya Healthcare, marking a significant milestone in its 40-year history.
NASDAQ
Cross Country Healthcare has agreed to be acquired by Aya Healthcare in an all-cash transaction, representing a significant premium over its recent trading price.
NASDAQ
DEFR14A: Cross Country Healthcare Issues Supplement to Proxy Statement to Correct Extraneous Language
Cross Country Healthcare, Inc. releases a supplement to its Definitive Proxy Statement to correct extraneous language in the 'New Plan Benefits' section.
NASDAQ
Cross Country Healthcare, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Cross Country Healthcare's proxy statement highlights a successful 2023 and proposes a new omnibus incentive plan for continued growth and alignment with stockholder interests.